eMedicine Specialties > Cardiology > Myocardial Disease and Cardiomyopathies

Cardiac Cirrhosis

Author: Xiushui (Mike) Ren, MD, Clinical Cardiology Fellow, Division of Cardiology, Kanbar Cardiac Center, California Pacific Medical Center
Coauthor(s): Allan Hiroshi Andrews, MD, Clinical Assistant Professor, Department of Internal Medicine, Medical College of Georgia; Staff Gastroenterologist, Department of Internal Medicine, Eisenhower Army Medical Center; Kent C Holtzmuller, MD, Consulting Staff, Department of Medicine, Division of Hepatology, Mecklenburg Medical Group
Contributor Information and Disclosures

Updated: Mar 16, 2008

Introduction

Background

Cardiac cirrhosis (congestive hepatopathy) includes a spectrum of hepatic derangements that occur in the setting of right-sided heart failure. Clinically, the signs and symptoms of congestive heart failure (CHF) dominate the disorder. Unlike cirrhosis caused by chronic alcohol use or viral hepatitis, the effect of cardiac cirrhosis on overall prognosis is unknown. Because of this, treatment is aimed at managing the patient's underlying heart failure.

Distinguish cardiac cirrhosis from ischemic hepatitis. The latter condition may involve massive hepatocellular necrosis caused by sudden cardiogenic shock or other hemodynamic collapse. Typically, sudden and dramatic serum hepatic transaminase elevations lead to its discovery. Although cardiac cirrhosis and ischemic hepatitis arise from distinct underlying cardiac lesions (right-sided heart failure in the former and left-sided failure in the latter), in clinical practice they may present together.

Despite its name, cardiac cirrhosis rarely satisfies strict pathologic criteria for cirrhosis. The terms congestive hepatopathy and chronic passive liver congestion are more accurate, but the name cardiac cirrhosis has become convention.

Cardiac cirrhosis. Congestive hepatopathy with la...

Cardiac cirrhosis. Congestive hepatopathy with large renal vein.

Cardiac cirrhosis. Congestive hepatopathy with la...

Cardiac cirrhosis. Congestive hepatopathy with large renal vein.


Cardiac cirrhosis. Congestive hepatopathy with la...

Cardiac cirrhosis. Congestive hepatopathy with large inferior vena cava.

Cardiac cirrhosis. Congestive hepatopathy with la...

Cardiac cirrhosis. Congestive hepatopathy with large inferior vena cava.


Pathophysiology

Decompensated right ventricular or biventricular heart failure causes transmission of elevated central venous pressures directly to the liver via the inferior vena cava and hepatic veins. At a cellular level, venous congestion impedes efficient drainage of sinusoidal blood flow into terminal hepatic venules. Sinusoidal stasis results in accumulation of deoxygenated blood, parenchymal atrophy, necrosis, collagen deposition, and, ultimately, fibrosis.

A separate theory proposes that cardiac cirrhosis is not simply a response to chronically increased pressure and sinusoidal stasis. That intrahepatic vascular lesions are confined to areas of the liver with higher fibrotic burden suggests that cardiac cirrhosis requires a higher grade of vascular obstruction, such as intrahepatic thrombosis, for its development. The theory proposes that thrombosis of sinusoids and terminal hepatic venules propagates to medium-sized hepatic veins and to portal vein branches, resulting in parenchymal extinction and fibrosis.

Frequency

United States

Cardiac cirrhosis rarely occurs in the United States. Its true prevalence is difficult to estimate, since the disease typically remains subclinical and undiagnosed. The incidence of cardiac cirrhosis at autopsy has decreased significantly over the past several decades. This may be due to lower rates of uncorrected rheumatic heart disease and constrictive pericardial disease.

Mortality/Morbidity

The effect of cardiac cirrhosis on mortality and morbidity rates is unknown. The severity of the patient's underlying cardiac disease, which is typically advanced and chronic, is the major determinant of overall outcome.

Sex

Comparative sex data for cardiac cirrhosis do not exist. However, because CHF is more common in men than women in the United States, the same is likely for cardiac cirrhosis.1

Age

No published data exist. However, the prevalence of cardiac cirrhosis in the United States, like that of CHF, almost certainly increases with age.

Clinical

History

Symptoms of CHF almost always mask gastrointestinal symptoms. Symptoms typically progress insidiously but may present suddenly and dramatically in cases of constrictive pericarditis or acute right ventricular decompensation. Patients may present with asymptomatic liver enzyme abnormalities, jaundice, and right upper quadrant discomfort. Case reports of fulminant hepatic failure have also been reported.

  • In addition to CHF, a patient's past medical history is likely to include one or more of the following:
  • Symptoms may be divided into those that accompany right ventricular heart failure and the additional findings of biventricular failure.
    • Symptoms associated with isolated right-sided heart failure
      • Dependent edema and weight gain
      • Increased abdominal girth
      • Right upper quadrant abdominal pain
      • Nocturia
      • Progressive fatigue
      • Anorexia, nausea, and vomiting
    • Symptoms associated with biventricular heart failure
      • Progressive dyspnea
      • Orthopnea
      • Paroxysmal nocturnal dyspnea
      • Wheezing and/or cough (ie, cardiac asthma)
      • Anxiety: Multifactorial causes include dyspnea, palpitations, and increased sympathetic tone.

Physical

Signs of heart failure dominate the physical examination findings.

  • Edema typically occurs in the lower extremities and dependent regions, which may progress to anasarca in cases of advanced and untreated heart failure. Chronic edema may be associated with lower extremity pigmentation, induration, and cellulitis.
  • Jugular venous pressure is elevated.
    • Further distention of neck veins may be elicited with application of pressure over the right upper quadrant for as long as 1 minute (ie, hepatojugular reflux).
    • Paradoxical rise in jugular venous pressure during inspiration (ie, Kussmaul sign) may indicate constrictive pericarditis, right ventricular heart failure, tricuspid stenosis, or cor pulmonale.
    • Right atrial pressure recordings reveal large a waves, indicating elevated right atrial pressure that may appear as presystolic liver pulsations.
    • Prominent v waves with rapid y descent indicate tricuspid regurgitation. Progression to a systolic, or c-v, wave occurs in severe tricuspid insufficiency and may appear as systolic liver pulsations.2
  • Rales on lung examination indicate biventricular CHF. Decreased basilar breath sounds from pleural effusion also are common.
  • Cardiac examination may reveal abnormalities related to right ventricular failure, tricuspid regurgitation, or both.
    • Abnormal systolic sternal or left parasternal lift signifies both pulmonary and right ventricular hypertension.
    • Right ventricular third and fourth heart sounds commonly are appreciated at the lower left sternal border of the sternum or over the xiphoid. Right ventricular S 3 suggests right ventricular failure. Right ventricular S 4 results from right atrial contraction into a noncompliant right ventricle. Inspiration increases the intensity of both extra heart sounds.
    • The holosystolic, high-pitched, blowing murmur of tricuspid insufficiency often accompanies severe right ventricular dilation and failure. The murmur is best heard at the lower left sternal border. But in cases of severe right ventricular enlargement, the murmur may be displaced as far laterally as the left midclavicular line. The murmur intensifies with inspiration and decreases with expiration.
    • Signs of pulmonary hypertension include a closely split S 2 with a loud pulmonic component. The Graham Steell murmur of pulmonary hypertensive pulmonic regurgitation is a high-pitched, blowing diastolic murmur beginning with a loud P2 and continuing through most of diastole.
  • Hepatomegaly is common, usually presenting as a firm, hard liver.
    • Elevated hydrostatic pressure within the hepatic veins and the peritoneal venous drainage system causes cardiac ascites. Protein-losing enteropathy with subsequent reduction of plasma oncotic pressure also may exacerbate ascites.
    • Splenomegaly may be found.
    • Fewer than 10% of patients exhibit jaundice.
    • Hepatic encephalopathy is rare.
  • Anorexia, weight loss, and malnutrition (ie, cardiac cachexia) indicate advanced underlying heart disease.

Causes

Causes of cardiac cirrhosis mirror the many etiologies of right-sided CHF. Although inferior vena caval thrombosis and Budd-Chiari syndrome exhibit similar pathophysiology, they are categorized separately and are not included as causes of cardiac cirrhosis.

The most frequent causes of cardiac cirrhosis are the following:

  • Ischemic heart disease (31%)
  • Cardiomyopathy (23%)
  • Valvular heart disease (23%)
  • Primary lung disease (15%)
  • Pericardial disease (8%)

More on Cardiac Cirrhosis

Overview: Cardiac Cirrhosis
Differential Diagnoses & Workup: Cardiac Cirrhosis
Treatment & Medication: Cardiac Cirrhosis
Follow-up: Cardiac Cirrhosis
Multimedia: Cardiac Cirrhosis
References

References

  1. Burns RB, McCarthy EP, Moskowitz MA. Outcomes for older men and women with congestive heart failure. J Am Geriatr Soc. Mar 1997;45(3):276-80. [Medline].

  2. Shapira, Y, Porter, A, Wurzel, M. Evaluation of tricuspid regurgitation severity: echocardiographic and clinical correlation. J Am Soc Echocardiogr. Jun 1998;11(6):652-9. [Medline].

  3. Runyon BA. Cardiac ascites: a characterization. J Clin Gastroenterol. Aug 1988;10(4):410-2. [Medline].

  4. Wanless IR, Liu JJ, Butany J. Role of thrombosis in the pathogenesis of congestive hepatic fibrosis (cardiac cirrhosis). Hepatology. May 1995;21(5):1232-7. [Medline].

  5. Arcidi JM, Moore GW, Hutchins GM. Hepatic morphology in cardiac dysfunction: a clinicopathologic study of 1000 subjects at autopsy. Am J Pathol. Aug 1981;104(2):159-66. [Medline].

  6. Fava M, Meneses L, Loyola S, Castro P, Barahona F. TIPSS Procedure in the Treatment of a Single Patient After Recent Heart Transplantation Because of Refractory Ascites Due to Cardiac Cirrhosis. Cardiovasc Intervent Radiol. December 2007;[Medline][Full Text].

  7. Cotran RS. Robbins Pathologic Basis of Disease. 6th ed. Philadelphia: WB Saunders Co; 1999:883.

  8. Crawford MH. Inspection and Palpation of Venous and Arterial Pulses. American Heart Association;1990:3-14.

  9. Dunn GD, Hayes P, Breen KJ. The liver in congestive heart failure: a review. Am J Med Sci. 1973;265:174.

  10. Feldman M. Sleisenger & Fordtran's Gastointestinal and Liver Disease. 1998. 6th ed. Philadelphia: WB Saunders Co; 1195.

  11. Goldman L. Cecil Textbook of Medicine. ed. Philadelphia: WB Saunders Co; 2000:211-213.

  12. Kircher BJ, Himelman RB, Schiller NB. Noninvasive estimation of right atrial pressure from the inspiratory collapse of the inferior vena cava. Am J Cardiol. Aug 15 1990;66(4):493-6. [Medline].

  13. Kubo SH, Walter BA, John DH. Liver function abnormalities in chronic heart failure. Influence of systemic hemodynamics. Arch Intern Med. Jul 1987;147(7):1227-30. [Medline].

  14. Moreno FL, Hagan AD, Holmen JR. Evaluation of size and dynamics of the inferior vena cava as an index of right-sided cardiac function. Am J Cardiol. Feb 1 1984;53(4):579-85.

  15. Naschitz JE, Slobodin G, Lewis RJ. Heart diseases affecting the liver and liver diseases affecting the heart. Am Heart J. Jul 2000;140(1):111-20. [Medline].

  16. Richman SM, Delman AJ, Grob D. Alterations in indices of liver function in congestive heart failure with particular reference to serum enzymes. Am J Med. Feb 1961;30:211-225.

  17. Schlant RC, Hurst JW. Examination of the Precordium: Inspection and Palpation. American Heart Association;1990:15-16.

  18. Sekiyama T, Nagano T, Aramaki T. [Congestive (cardiac) cirrhosis]. Nippon Rinsho. Jan 1994;52(1):229-33. [Medline].

  19. Shaver JA, Leonard JJ, Leon DF. Auscultation of the Heart. American Heart Association;1990:28-49.

  20. [Guideline] Williams JF. Guidelines for the evaluation and management of heart failure. Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Evaluation and Management of Heart Failure). Circulation. Nov 1 1995;92(9):2764-84. [Medline].

Further Reading

Keywords

congestive hepatopathy, congestive cirrhosis, congestive liver fibrosis, congestive hepatic fibrosis, chronic passive liver congestion, CPC, congestive heart failure, CHF, centrolobular necrosis, cardiac sclerosis

Contributor Information and Disclosures

Author

Xiushui (Mike) Ren, MD, Clinical Cardiology Fellow, Division of Cardiology, Kanbar Cardiac Center, California Pacific Medical Center
Xiushui (Mike) Ren, MD is a member of the following medical societies: Alpha Omega Alpha, American College of Cardiology, and American Society of Echocardiography
Disclosure: Nothing to disclose.

Coauthor(s)

Allan Hiroshi Andrews, MD, Clinical Assistant Professor, Department of Internal Medicine, Medical College of Georgia; Staff Gastroenterologist, Department of Internal Medicine, Eisenhower Army Medical Center
Allan Hiroshi Andrews, MD is a member of the following medical societies: American College of Physicians-American Society of Internal Medicine
Disclosure: Nothing to disclose.

Kent C Holtzmuller, MD, Consulting Staff, Department of Medicine, Division of Hepatology, Mecklenburg Medical Group
Kent C Holtzmuller, MD is a member of the following medical societies: American Association for the Study of Liver Diseases, American College of Gastroenterology, American College of Physicians, American Gastroenterological Association, and American Medical Association
Disclosure: Nothing to disclose.

Medical Editor

Justin D Pearlman, MD, PhD, ME, MA, Director of Advanced Cardiovascular Imaging, Professor of Medicine, Professor of Radiology, Adjunct Professor, Thayer Bioengineering and Computer Science, Dartmouth-Hitchcock Medical Center
Justin D Pearlman, MD, PhD, ME, MA is a member of the following medical societies: American College of Cardiology, American College of Physicians, American Federation for Medical Research, International Society for Magnetic Resonance in Medicine, and Radiological Society of North America
Disclosure: Nothing to disclose.

Pharmacy Editor

Francisco Talavera, PharmD, PhD, Senior Pharmacy Editor, eMedicine
Disclosure: eMedicine Salary Employment

Managing Editor

Ronald J Oudiz, MD, FACP, FACC, Associate Professor of Medicine, Division of Cardiology, The David Geffen School of Medicine at UCLA; Director, Liu Center for Pulmonary Hypertension, LA Biomedical Research Institute at Harbor-UCLA Medical Center
Ronald J Oudiz, MD, FACP, FACC is a member of the following medical societies: American College of Cardiology, American College of Chest Physicians, American College of Physicians, American Heart Association, and American Thoracic Society
Disclosure: Actelion Grant/research funds Clinical Trials + honoraria; Encysive Grant/research funds Clinical Trials + honoraria; Gilead Grant/research funds Clinical Trials + honoraria; Pfizer Grant/research funds Clinical Trials + honoraria; United Therapeutics Grant/research funds Clinical Trials + honoraria; Lilly Grant/research funds Clinical Trials + honoraria; LungRx  Clinical Trials + honoraria

CME Editor

Amer Suleman, MD, Consultant in Electrophysiology and Cardiovascular Medicine, Department of Internal Medicine, Division of Cardiology, Medical City Dallas Hospital
Amer Suleman, MD is a member of the following medical societies: American College of Physicians, American Heart Association, American Institute of Stress, American Society of Hypertension, Federation of American Societies for Experimental Biology, Royal Society of Medicine, and Society of Cardiac Angiography and Interventions
Disclosure: Nothing to disclose.

Chief Editor

Michael E Zevitz, MD, Assistant Professor of Medicine, Finch University of the Health Sciences, The Chicago Medical School; Consulting Staff, Private Practice
Michael E Zevitz, MD is a member of the following medical societies: American College of Cardiology, American College of Physicians, American Medical Association, and Michigan State Medical Society
Disclosure: Nothing to disclose.

 
 
HONcode

We subscribe to the
HONcode principles of the
Health On the Net Foundation

All material on this website is protected by copyright, Copyright© 1994- by Medscape.
This website also contains material copyrighted by 3rd parties.

DISCLAIMER: The content of this Website is not influenced by sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.